The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524
Self-citationLag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Gromeier, M., Alexander, L., & Wimmer, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2370 · Cited by 330
Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234
Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patients
Sanchez‐Correa, B., Gayoso, I., Bergua, J. M., Casado, J. G., Morgado, S., Solana, R., & Tarazona, R. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.15 · Cited by 228
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Poliovirus tropism and attenuation are determined after internal ribosome entry
Kauder, S. E., & Racaniello, V. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421323 · Cited by 83
Georgescu, M. M., Balanant, J., Macadam, A., Otelea, D., Combiescu, M., Combiescu, A. A., Crainic, R., & Delpeyroux, F. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7758-7768.1997 · Cited by 83
Proteinase 2AproIs Essential for Enterovirus Replication in Type I Interferon-Treated Cells
Morrison, J. M., & Racaniello, V. R. (2009) · Journal of Virology · doi:10.1128/jvi.02177-08 · Cited by 51
Cited by
Treg Heterogeneity, Function, and Homeostasis
Shevyrev, D., & Tereshchenko, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03100 · Cited by 404
NK Cell-Based Immune Checkpoint Inhibition
Khan, M., Arooj, S., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00167 · Cited by 356
Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications
Jin, W. (2020) · Cancers · doi:10.3390/cancers12051339 · Cited by 86
Li, Y., Zhang, Y., Cao, G., Zheng, X., Sun, C., Wei, H., Tian, Z., Xiao, W., Sun, R., & Sun, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01112-3 · Cited by 51
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
Lee, B.-H., Kim, J.-H., Kang, K.-W., Lee, S.-R., Park, Y., Sung, H.-J., & Kim, B.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10051099 · Cited by 19
Metadata
- Authors
- Kučan Brlić, P., Lenac Roviš, T., Cinamon, G., Tsukerman, P., Mandelboim, O., & Jonjić, S.
- Venue
- Cellular & Molecular Immunology
- Published
- 2018-10-01
- Volume
- 16
- Issue
- 1
- Pages
- 40-52
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- OpenAlex
- W2892839743
- Cited by
- 171
- References
- 10
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting PVR (CD155) and its receptors in anti-tumor therapy. https://app.cochat.ai/papers/10.1038/s41423-018-0168-y
- The paper
- Kučan Brlić, P., Lenac Roviš, T., Cinamon, G., Tsukerman, P., Mandelboim, O., & Jonjić, S. (2019). Targeting PVR (CD155) and its receptors in anti-tumor therapy. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-018-0168-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.